메뉴 건너뛰기




Volumn 55, Issue 1, 2014, Pages 132-140

Concomitant impact of high-sensitivity C-reactive protein and renal dysfunction in patients with acute myocardial infarction

(62)  Kang, Yong Un a   Kim, Min Jee a   Choi, Joon Seok a   Kim, Chang Seong a   Bae, Eun Hui a   Ma, Seong Kwon a   Ahn, Young Keun a,b,f   Jeong, Myung Ho a,b,f   Kim, Young Jo c,f   Cho, Myeong Chan d,f   Kim, Chong Jin e,f   Kim, Soo Wan a   Chae, Sung Chull f   Kim, Jong Hyun f   Hur, Seung Ho f   Seong, In Whan f   Choi, Dong Hoon f   Chae, Jei Keon f   Hong, Taek Jong f   Rhew, Jae Young f   more..

f NONE

Author keywords

C reactive protein; Glomerular filtration rate; Myocardial infarction

Indexed keywords

C REACTIVE PROTEIN; CREATINE KINASE MB; TROPONIN I; TROPONIN T;

EID: 84890767165     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2014.55.1.132     Document Type: Article
Times cited : (4)

References (27)
  • 1
    • 0242441465 scopus 로고    scopus 로고
    • Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention
    • Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 2003;42:1050-65.
    • (2003) Hypertension , vol.42 , pp. 1050-1065
    • Sarnak, M.J.1    Levey, A.S.2    Schoolwerth, A.C.3    Coresh, J.4    Culleton, B.5    Hamm, L.L.6
  • 3
    • 4644221457 scopus 로고    scopus 로고
    • Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
    • Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-305.
    • (2004) N Engl J Med , vol.351 , pp. 1296-1305
    • Go, A.S.1    Chertow, G.M.2    Fan, D.3    McCulloch, C.E.4    Hsu, C.Y.5
  • 4
    • 0037420121 scopus 로고    scopus 로고
    • Why is chronic kidney disease the "spoiler" for cardiovascular outcomes?
    • McCullough PA. Why is chronic kidney disease the "spoiler" for cardiovascular outcomes? J Am Coll Cardiol 2003;41:725-8.
    • (2003) J Am Coll Cardiol , vol.41 , pp. 725-728
    • McCullough, P.A.1
  • 5
    • 0035134192 scopus 로고    scopus 로고
    • End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link?
    • Arici M, Walls J. End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link? Kidney Int 2001;59:407-14.
    • (2001) Kidney Int , vol.59 , pp. 407-414
    • Arici, M.1    Walls, J.2
  • 6
    • 0033552883 scopus 로고    scopus 로고
    • Atherosclerosis--an inflammatory disease
    • Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med 1999;340:115-26.
    • (1999) N Engl J Med , vol.340 , pp. 115-126
    • Ross, R.1
  • 7
    • 0347716452 scopus 로고    scopus 로고
    • The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease
    • Muntner P, Hamm LL, Kusek JW, Chen J, Whelton PK, He J. The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease. Ann Intern Med 2004;140: 9-17.
    • (2004) Ann Intern Med , vol.140 , pp. 9-17
    • Muntner, P.1    Hamm, L.L.2    Kusek, J.W.3    Chen, J.4    Whelton, P.K.5    He, J.6
  • 8
    • 26944473274 scopus 로고    scopus 로고
    • C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease
    • Menon V, Greene T, Wang X, Pereira AA, Marcovina SM, Beck GJ, et al. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int 2005;68:766-72.
    • (2005) Kidney Int , vol.68 , pp. 766-772
    • Menon, V.1    Greene, T.2    Wang, X.3    Pereira, A.A.4    Marcovina, S.M.5    Beck, G.J.6
  • 9
    • 33746012877 scopus 로고    scopus 로고
    • Do inflammatory markers add predictive information of death beyond that provided by age and comorbidity in chronic renal failure patients?
    • Caravaca F, Martín MV, Barroso S, Ruiz B, Hernández-Gallego R. Do inflammatory markers add predictive information of death beyond that provided by age and comorbidity in chronic renal failure patients? Nephrol Dial Transplant 2006;21:1575-81.
    • (2006) Nephrol Dial Transplant , vol.21 , pp. 1575-1581
    • Caravaca, F.1    Martín, M.V.2    Barroso, S.3    Ruiz, B.4    Hernández-Gallego, R.5
  • 10
    • 79958093858 scopus 로고    scopus 로고
    • Impact of cardiac rehabilitation on mortality and cardiovascular events after percutaneous coronary intervention in the community
    • Goel K, Lennon RJ, Tilbury RT, Squires RW, Thomas RJ. Impact of cardiac rehabilitation on mortality and cardiovascular events after percutaneous coronary intervention in the community. Circulation 2011;123:2344-52.
    • (2011) Circulation , vol.123 , pp. 2344-2352
    • Goel, K.1    Lennon, R.J.2    Tilbury, R.T.3    Squires, R.W.4    Thomas, R.J.5
  • 11
    • 40849092775 scopus 로고    scopus 로고
    • Estimated glomerular filtration rate, inflammation, and cardiovascular events after an acute coronary syndrome
    • Mielniczuk LM, Pfeffer MA, Lewis EF, Blazing MA, de Lemos JA, Shui A, et al. Estimated glomerular filtration rate, inflammation, and cardiovascular events after an acute coronary syndrome. Am Heart J 2008;155:725-31.
    • (2008) Am Heart J , vol.155 , pp. 725-731
    • Mielniczuk, L.M.1    Pfeffer, M.A.2    Lewis, E.F.3    Blazing, M.A.4    de Lemos, J.A.5    Shui, A.6
  • 14
    • 71649114494 scopus 로고    scopus 로고
    • Clinical implications of JUPITER (Justification for the Use of statins in Prevention: An Intervention Trial Evaluating Rosuvastatin) in a U.S. population insights from the ARIC (Atherosclerosis Risk in Communities) study
    • Yang EY, Nambi V, Tang Z, Virani SS, Boerwinkle E, Hoogeveen RC, et al. Clinical implications of JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) in a U.S. population insights from the ARIC (Atherosclerosis Risk in Communities) study. J Am Coll Cardiol 2009;54: 2388-95.
    • (2009) J Am Coll Cardiol , vol.54 , pp. 2388-2395
    • Yang, E.Y.1    Nambi, V.2    Tang, Z.3    Virani, S.S.4    Boerwinkle, E.5    Hoogeveen, R.C.6
  • 16
    • 0036176161 scopus 로고    scopus 로고
    • K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
    • National Kidney Foundation
    • National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39(2 Suppl 1):S1-266.
    • (2002) Am J Kidney Dis , vol.39 , Issue.2 SUPPL. 1
  • 17
    • 20144387681 scopus 로고    scopus 로고
    • Cardiovascular mortality risk in chronic kidney disease: Comparison of traditional and novel risk factors
    • Shlipak MG, Fried LF, Cushman M, Manolio TA, Peterson D, Stehman-Breen C, et al. Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA 2005;293:1737-45.
    • (2005) JAMA , vol.293 , pp. 1737-1745
    • Shlipak, M.G.1    Fried, L.F.2    Cushman, M.3    Manolio, T.A.4    Peterson, D.5    Stehman-Breen, C.6
  • 18
    • 38649103152 scopus 로고    scopus 로고
    • Amino-terminal pro-B-type natriuretic peptide testing in renal disease
    • DeFilippi C, van Kimmenade RR, Pinto YM. Amino-terminal pro-B-type natriuretic peptide testing in renal disease. Am J Cardiol 2008;101:82-8.
    • (2008) Am J Cardiol , vol.101 , pp. 82-88
    • DeFilippi, C.1    van Kimmenade, R.R.2    Pinto, Y.M.3
  • 19
    • 0142157737 scopus 로고    scopus 로고
    • Malnutrition-inflammation complex syndrome in dialysis patients: Causes and consequences
    • Kalantar-Zadeh K, Ikizler TA, Block G, Avram MM, Kopple JD. Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis 2003;42:864-81.
    • (2003) Am J Kidney Dis , vol.42 , pp. 864-881
    • Kalantar-Zadeh, K.1    Ikizler, T.A.2    Block, G.3    Avram, M.M.4    Kopple, J.D.5
  • 20
    • 84862797441 scopus 로고    scopus 로고
    • GFR and cardiovascular outcomes after acute myocardial infarction: Results from the Korea Acute Myocardial Infarction Registry
    • Bae EH, Lim SY, Cho KH, Choi JS, Kim CS, Park JW, et al. GFR and cardiovascular outcomes after acute myocardial infarction: results from the Korea Acute Myocardial Infarction Registry. Am J Kidney Dis 2012;59:795-802.
    • (2012) Am J Kidney Dis , vol.59 , pp. 795-802
    • Bae, E.H.1    Lim, S.Y.2    Cho, K.H.3    Choi, J.S.4    Kim, C.S.5    Park, J.W.6
  • 21
    • 0037078969 scopus 로고    scopus 로고
    • Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events
    • Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002;347:1557-65.
    • (2002) N Engl J Med , vol.347 , pp. 1557-1565
    • Ridker, P.M.1    Rifai, N.2    Rose, L.3    Buring, J.E.4    Cook, N.R.5
  • 22
    • 1842587885 scopus 로고    scopus 로고
    • C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease
    • Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004;350:1387-97.
    • (2004) N Engl J Med , vol.350 , pp. 1387-1397
    • Danesh, J.1    Wheeler, J.G.2    Hirschfield, G.M.3    Eda, S.4    Eiriksdottir, G.5    Rumley, A.6
  • 23
    • 46849110373 scopus 로고    scopus 로고
    • Chronic inflammation and mortality in haemodialysis: Effect of different renal replacement therapies. Results from the RISCAVID study
    • Panichi V, Rizza GM, Paoletti S, Bigazzi R, Aloisi M, Barsotti G, et al. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study. Nephrol Dial Transplant 2008;23:2337-43.
    • (2008) Nephrol Dial Transplant , vol.23 , pp. 2337-2343
    • Panichi, V.1    Rizza, G.M.2    Paoletti, S.3    Bigazzi, R.4    Aloisi, M.5    Barsotti, G.6
  • 24
    • 0034119307 scopus 로고    scopus 로고
    • The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease
    • Klahr S, Morrissey JJ. The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease. Kidney Int Suppl 2000;75:S7-14.
    • (2000) Kidney Int Suppl , vol.75
    • Klahr, S.1    Morrissey, J.J.2
  • 25
    • 0037180771 scopus 로고    scopus 로고
    • Inflammation in atherosclerosis
    • Libby P. Inflammation in atherosclerosis. Nature 2002;420:868-74.
    • (2002) Nature , vol.420 , pp. 868-874
    • Libby, P.1
  • 26
    • 0033597123 scopus 로고    scopus 로고
    • Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression of membrane type 1-matrix metalloproteinase
    • Rajavashisth TB, Liao JK, Galis ZS, Tripathi S, Laufs U, Tripathi J, et al. Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression of membrane type 1-matrix metalloproteinase. J Biol Chem 1999;274:11924-9.
    • (1999) J Biol Chem , vol.274 , pp. 11924-11929
    • Rajavashisth, T.B.1    Liao, J.K.2    Galis, Z.S.3    Tripathi, S.4    Laufs, U.5    Tripathi, J.6
  • 27
    • 77949332406 scopus 로고    scopus 로고
    • Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: A secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention-an Intervention Trial Evaluating Rosuvastatin) trial
    • Ridker PM, MacFadyen J, Cressman M, Glynn RJ. Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: a secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention-an Intervention Trial Evaluating Rosuvastatin) trial. J Am Coll Cardiol 2010;55:1266-73.
    • (2010) J Am Coll Cardiol , vol.55 , pp. 1266-1273
    • Ridker, P.M.1    McFadyen, J.2    Cressman, M.3    Glynn, R.J.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.